Published in Gene Therapy Weekly, September 11th, 2003
The 55-year-old patient had dinner afterward and was doing fine, Dr. Michael Kaplitt of Weill Cornell Medical College said a few hours after completing the procedure.
The man, whom the surgeon did not identify, is the first of a planned 12 patients for a study focusing on the procedure's safety, rather than whether or not it relieves symptoms.
"Our whole goal here is to prove this is safe before we move on," Kaplitt said.
Kaplitt said it...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.